Cytokinetics inc (CYTK)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities:
Net loss

-131,731

-121,692

-117,520

-109,964

-105,374

-106,289

-120,306

-130,646

-132,204

-127,790

-80,148

-14,429

3,041

16,453

67

-42,144

-41,084

-37,501

-19,829

-16,951

-14,774

-14,646

-16,558

-23,175

-29,842

-33,717

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense on liability related to sale of future royalties

21,624

20,737

19,945

19,183

18,457

17,767

17,100

16,459

15,850

14,028

9,954

6,036

2,307

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash equity-related expense

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Non-cash stock-based compensation expense

0

-

-

-

0

-

-

-

-

-

-

-

-

7,146

6,614

5,869

5,282

4,567

4,105

3,875

3,532

3,330

3,100

3,054

3,325

3,597

0

0

0

Depreciation and amortization of property and equipment

1,415

1,293

582

514

852

1,239

0

0

0

-

-

-

-

-

-

637

614

589

575

555

530

490

441

416

414

433

0

0

0

Depreciation of property and equipment

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest receivable and amortization on investments

-1,761

-2,587

-2,023

-2,385

-2,306

-1,677

-1,237

-500

96

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net gain on disposal of equipment

-

-

-

-

-

-

-

-

-

67

101

98

100

18

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to debt

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to long-term debt

-

-

-

-

-

-

-

-

-

-

-

555

554

534

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-1,461

2,932

-2,580

8,757

4,128

1,119

-844

236

-872

1,088

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract assets

-2,472

-4,554

3,829

-95

-4,024

-5,154

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract assets

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-970

-

-1,142

-314

-1,146

46,641

1,189

318

1,787

0

0

0

0

Prepaid and other assets

1,930

3,862

1,954

637

572

-1,817

-2,173

-2,690

-484

2,161

2,093

-1,230

904

707

92

3,981

722

396

679

263

382

-274

199

116

-74

-818

0

0

0

Operating lease right-of-use assets

-3,712

-3,552

-2,631

-1,733

-856

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

980

4,396

1,388

3,858

124

-1,490

-3,235

-573

-648

1,457

4,494

-1,031

2,434

1,698

-1,195

1,285

-802

755

301

653

30

-2,178

-104

-792

343

1,656

0

0

0

Accrued and other liabilities

-766

-2,168

-1,857

-3,689

-5,596

-2,063

-1,211

3,081

1,682

766

1,166

3,890

9,461

8,945

9,301

3,556

4,048

2,995

705

-958

-3,723

-2,865

-3,868

240

3,066

3,523

0

0

0

Contract liabilities

-

-

-

-

-

-18,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-4,072

-3,876

-2,854

-1,854

-916

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Related party payables and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-150

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-690

8,175

9,212

2,202

421

-14,452

-15,390

-12,742

20,376

20,302

20,985

17,399

0

0

0

-

-

-

-

Net cash used in operating activities

-94,135

-90,907

-84,179

-96,146

-98,315

-101,215

-112,959

-106,207

-110,622

-101,759

141

13,502

33,545

36,982

-50,789

-49,014

-46,983

4,883

6,695

7,527

7,338

-44,843

-49,142

-29,318

-13,318

-7,718

0

0

0

Cash flows from investing activities:
Purchases of investments

247,180

277,883

193,594

208,177

257,295

240,224

214,384

171,090

131,867

240,413

279,646

275,980

227,782

145,158

100,877

120,620

115,872

115,566

108,457

85,011

101,413

107,043

104,392

128,052

127,143

79,434

0

0

0

Sales and maturities of investments

199,721

205,795

252,170

255,100

262,807

246,232

225,231

219,011

200,225

177,462

144,036

114,537

86,098

94,645

117,094

133,920

144,718

132,190

106,018

81,380

95,032

104,098

100,951

106,921

86,979

78,444

0

0

0

Purchases of property and equipment

3,403

2,619

1,523

875

885

889

1,459

1,552

1,750

2,877

2,951

2,806

2,564

1,596

946

693

852

562

605

652

901

1,104

1,109

1,078

698

542

0

0

0

Net cash provided by investing activities

-50,862

-74,707

57,067

46,062

4,641

5,133

9,388

46,369

66,608

-65,828

-138,561

-164,248

-144,215

-52,076

15,305

12,640

27,995

16,063

-3,044

-4,283

-7,282

-4,049

-4,540

-22,199

-40,849

-1,519

0

0

0

Cash flows from financing activities:
Proceeds from and payments for stock based award activities, net

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Claims settlement under Section 16(b)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock under at-the-market offering, net of issuance costs

31,097

36,214

36,214

24,814

5,117

0

0

-8

94,869

112,224

112,224

112,232

17,355

0

0

0

0

-

-

-

-

48,971

0

0

0

-

-

-

-

Proceeds from common stock award exercise

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of future royalties, net of issuance costs

-

-

-

-

-

-

-

-

-

90,621

90,621

90,621

90,621

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock related to sale of future royalties, net of issuance costs

-

-

-

-

-

-

-

-

-

7,560

7,560

7,560

7,560

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from long-term debt, net of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

14,996

29,886

29,886

29,886

14,890

0

0

0

-

-

-

-

-

-

-

-

Issuance of equity for stock-based awards and warrants, net

-

-

-

-

-

-

-

-

-13,531

-14,253

-14,035

-13,320

-2,229

-1,896

-1,263

-700

-152

-352

-302

-138

-132

22

-7,462

-6,979

-6,944

-7,038

0

0

0

Net cash (used in) provided by financing activities

155,364

159,791

39,122

37,490

18,072

13,132

14,875

6,082

109,661

225,919

224,440

223,733

117,765

16,892

39,822

39,259

38,711

23,915

9,404

9,240

9,234

48,949

47,331

46,815

54,263

14,488

0

0

0

Net increase (decrease) in cash and cash equivalents

10,367

-5,823

12,010

-12,594

-75,602

-82,950

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

7,095

1,798

4,338

2,885

19,723

44,861

13,055

12,484

9,290

57

-6,351

-4,702

96

5,251

0

0

0

Non-cash investing and financing activities:
Right-of-use assets recognized in exchange for lease obligations

1,107

10,687

10,687

10,687

10,686

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-